Zhang D., Zhang Y., Sun B. 2022. The molecular mechanisms of liver fibrosis and its potential therapy in application. Int. J. Mol. Sci. 23 (20), 12572. https://doi.org/10.3390/ijms232012572
Article CAS PubMed PubMed Central Google Scholar
Graupera I., Isus L., Coll M., Pose E., Díaz A., Vallverdú J., Rubio-Tomás T., Martínez-Sánchez C., Huelin P., Llopis M., Solé C., Fondevila C., Lozano J.J., Sancho-Bru P., Ginès P., Aloy P. 2022. Molecular characterization of chronic liver disease dynamics: from liver fibrosis to acute-on-chronic liver failure. JHEP Rep. 4 (6), 100482. https://doi.org/10.1016/j.jhepr.2022.100482
Article PubMed PubMed Central Google Scholar
Kachanova O., Lobov A., Malashicheva A. 2022. The role of the Notch signaling pathway in recovery of cardiac function after myocardial infarction. Int. J. Mol. Sci. 23 (20), 12509. https://doi.org/10.3390/ijms232012509
Article CAS PubMed PubMed Central Google Scholar
Yuan C., Ni L., Zhang C., Wu X. 2020. The role of Notch3 signaling in kidney disease. Oxid. Med. Cell Longev. 2020, 1809408. https://doi.org/10.1155/2020/1809408
Salazar J.L., Yang S.A., Yamamoto S. 2020. Post-developmental roles of notch signaling in the nervous system. Biomolecules. 10 (7), 985. https://doi.org/10.3390/biom10070985
Article CAS PubMed PubMed Central Google Scholar
Hosseini-Alghaderi S., Baron M. 2020. Notch3 in development, health and disease. Biomolecules. 10(3), 485. https://doi.org/10.3390/biom10030485
Article CAS PubMed PubMed Central Google Scholar
Chen Y., Gao W.K., Shu Y.Y., Ye J. 2022. Mechanisms of ductular reaction in non-alcoholic steatohepatitis. World J. Gastroenterol. 28 (19), 2088‒2099. https://doi.org/10.3748/wjg.v28.i19.2088
Article CAS PubMed PubMed Central Google Scholar
Vera L., Garcia-Olloqui P., Petri E., Viñado A.C., Valera P.S., Blasco-Iturri Z., Calvo I.A., Cenzano I., Ruppert C., Zulueta J.J., Prosper F., Saez B., Pardo-Saganta A. 2021. Notch3 deficiency attenuates pulmonary fibrosis and impedes lung-function decline. Am. J. Respir. Cell Mol. Biol. 64 (4), 465‒476. https://doi.org/10.1165/rcmb.2020-0516OC
Article CAS PubMed Google Scholar
Adams J.M., Jafar-Nejad H. 2019. The roles of notch signaling in liver development and disease. Biomolecules. 9 (10), 608. https://doi.org/10.3390/biom9100608
Article CAS PubMed PubMed Central Google Scholar
Pelullo M., Zema S., Nardozza F., Checquolo S., Screpanti I., Bellavia D. 2019. Wnt, Notch, and TGF-β pathways impinge on hedgehog signaling complexity: an open window on cancer. Front. Genet. 10, 711. https://doi.org/10.3389/fgene.2019.00711
Article CAS PubMed PubMed Central Google Scholar
Dai Y., Hao P., Sun Z., Guo Z., Xu H., Xue L., Song H., Li Y., Li S., Gao M., Si T., Zhang Y., Qi Y. 2021. Liver knockout YAP gene improved insulin resistance-induced hepatic fibrosis. J. Endocrinol. 249 (2), 149‒161. https://doi.org/10.1530/JOE-20-0561
Article CAS PubMed Google Scholar
Yu H.X., Yao Y., Bu F.T., Chen Y., Wu Y.T., Yang Y., Chen X., Zhu Y., Wang Q., Pan X.Y., Meng X.M., Huang C., Li J. 2019. Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells. Mol. Immunol. 107, 29‒40. https://doi.org/10.1016/j.molimm.2019.01.004
Article CAS PubMed Google Scholar
Zheng C., Luo J., Yang Y., Dong R., Yu F.X., Zheng S. 2021. YAP activation and implications in patients and a mouse model of biliary atresia. Front. Pediatr. 8, 618226. https://doi.org/10.3389/fped.2020.618226
Article PubMed PubMed Central Google Scholar
He X., Tolosa M.F., Zhang T., Goru S.K., Ulloa Severino L., Misra P.S., McEvoy C.M., Caldwell L., Szeto S.G., Gao F., Chen X., Atin C., Ki V., Vukosa N., Hu C., Zhang J., Yip C., Krizova A., Wrana J.L., Yuen D.A. 2022. Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. JCI Insight. 7 (4), e146243. https://doi.org/10.1172/jci.insight.146243
Article PubMed PubMed Central Google Scholar
Wang M., Xie Z., Xu J., Feng Z. 2020. TWEAK/Fn14 axis in respiratory diseases. Clin. Chim. Acta. 509, 139‒148. https://doi.org/10.1016/j.cca.2020.06.007
Article CAS PubMed Google Scholar
Dwyer B.J., Jarman E.J., Gogoi-Tiwari J., Ferreira-Gonzalez S., Boulter L., Guest R.V., Kendall T.J., Kurian D., Kilpatrick A.M., Robson A.J., O’Duibhir E., Man T.Y., Campana L., Starkey Lewis P.J., Wigmore S.J., Olynyk J.K., Ramm G.A., Tirnitz-Parker J.E.E., Forbes S.J. 2021. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression. J. Hepatol. 74 (4), 860‒872. https://doi.org/10.1016/j.jhep.2020.11.018
Article CAS PubMed Google Scholar
Zhang Y., Zeng W., Xia Y. 2021. TWEAK/Fn14 axis is an important player in fibrosis. J. Cell. Physiol. 236 (5), 3304‒3316. https://doi.org/10.1002/jcp.30089
Article CAS PubMed Google Scholar
Lin Y., Dong M.Q., Liu Z.M., Xu M., Huang Z.H., Liu H.J., Gao Y., Zhou W. 2022. A strategy of vascular-targeted therapy for liver fibrosis. J. Hepatology. 76 (3), 660‒675. https://doi.org/10.1002/hep.32299
Lefere S., Devisscher L., Geerts A. 2020. Angiogenesis in the progression of non-alcoholic fatty liver disease. Acta Gastroenterol. Belg. 83 (2), 301‒307.
Yang L., Yue W., Zhang H., Zhang Z., Xue R., Dong C., Liu F., Chang N., Yang L., Li L. 2022. Dual targeting of angipoietin-1 and von Willebrand factor by microRNA-671-5p attenuates liver angiogenesis and fibrosis. Hepatol. Commun. 6 (6), 1425‒1442. https://doi.org/10.1002/hep4.1888
Article CAS PubMed PubMed Central Google Scholar
Friedman S.L., Pinzani M. 2022. Hepatic fibrosis 2022: unmet needs and a blueprint for the future. Hepatology. 75(2), 473‒488. https://doi.org/10.1002/hep.32285
Article CAS PubMed Google Scholar
Ray P., Stacer A.C., Fenner J., Cavnar S.P., Meguiar K., Brown M., Luker K.E., Luker G.D. 2015. CXCL12-γ in primary tumors drives breast cancer metastasis. Oncogene. 34 (16), 2043‒2051. https://doi.org/10.1038/onc.2014.157
Article CAS PubMed Google Scholar
Cui L.N., Zheng X.H., Yu J.H., Han Y. 2021. Role of CXCL12-CXCR4/CXCR7 signal axis in liver regeneration and liver fibrosis. Zhonghua Gan Zang Bing Za Zhi. 29 (9), 900‒903. https://doi.org/10.3760/cma.j.cn501113-20200721-00403
Article CAS PubMed Google Scholar
Chiraunyanann T., Changsri K., Sretapunya W., Yuenyongchaiwat K., Akekawatchai C. 2019. CXCL12 G801A polymorphism is associated with significant liver fibrosis in HIV-infected Thais: a cross-sectional study. Asian Pac. J. Allergy Immunol. 37 (3), 162‒170. https://doi.org/10.12932/AP-160917-0162
Article CAS PubMed Google Scholar
Zhang J., Li Y., Liu Q., Li R., Pu S., Yang L., Feng Y., Ma L. 2018. SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway. RSC Adv. 8 (54), 30919‒30924. https://doi.org/10.1039/c8ra04955f
Article CAS PubMed PubMed Central Google Scholar
Ahmad N., Ansari M.Y., Haqqi T.M. 2020. Role of iNOS in osteoarthritis: pathological and therapeutic aspects. J. Cell Physiol. 235 (10), 6366‒6376. https://doi.org/10.1002/jcp.29607
Article CAS PubMed PubMed Central Google Scholar
Kashfi K., Kannikal J., Nath N. 2021. Macrophage reprogramming and cancer therapeutics: role of iNOS-derived NO. Cells. 10 (11), 3194. https://doi.org/10.3390/cells10113194
Article CAS PubMed PubMed Central Google Scholar
Tsomidis I., Notas G., Xidakis C., Voumvouraki A., Samonakis D.N., Koulentaki M., Kouroumalis E. 2022. Enzymes of fibrosis in chronic liver disease. Biomedicines. 10 (12), 3179. https://doi.org/10.3390/biomedicines10123179
Article CAS PubMed PubMed Central Google Scholar
Lachowski D., Cortes E., Rice A., Pinato D., Rombouts K., Hernandez A.D.R. 2019. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis. Sci. Rep. 9 (1), 7299. https://doi.org/10.1038/s41598-019-43759-6
Article CAS PubMed PubMed Central Google Scholar
Maltais L.J., Blake J.A., Chu T., Lutz C.M., Eppig J.T., Jackson I. 2002. Rules and guidelines for mouse gene, allele, and mutation nomenclature: a condensed version. Genomics. 79 (4), 471‒474. https://doi.org/10.1006/geno.2002.6747
Article CAS PubMed Google Scholar
Everhart J.E., Wright E.C., Goodman Z.D., Dienstag J.L., Hoefs J.C., Kleiner D.E., Ghany M.G., Mills A.S., Nash S.R., Govindarajan S., Rogers T.E., Greenson J.K., Brunt E.M., Bonkovsky H.L., Morishima C., Litman H.J. 2010. HALT-C Trial Group. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 51 (2), 585‒594. https://doi.org/10.1002/hep.23315
Lebedeva E.I., Shchastny A.T., Babenko A.S. 2022. Stability dyna
留言 (0)